FI63674C - Foerfarande foer isolering och rening av immunologiskt aktivt polyribosylribitolfosfat (prp) - Google Patents

Foerfarande foer isolering och rening av immunologiskt aktivt polyribosylribitolfosfat (prp) Download PDF

Info

Publication number
FI63674C
FI63674C FI783269A FI783269A FI63674C FI 63674 C FI63674 C FI 63674C FI 783269 A FI783269 A FI 783269A FI 783269 A FI783269 A FI 783269A FI 63674 C FI63674 C FI 63674C
Authority
FI
Finland
Prior art keywords
prp
haemophilus influenzae
influenzae type
phosphate buffer
known per
Prior art date
Application number
FI783269A
Other languages
English (en)
Finnish (fi)
Other versions
FI783269A (fi
FI63674B (fi
Inventor
Joseph S-C Kuo
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI783269A publication Critical patent/FI783269A/fi
Application granted granted Critical
Publication of FI63674B publication Critical patent/FI63674B/fi
Publication of FI63674C publication Critical patent/FI63674C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI783269A 1977-10-28 1978-10-26 Foerfarande foer isolering och rening av immunologiskt aktivt polyribosylribitolfosfat (prp) FI63674C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84646677 1977-10-28
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US84648877 1977-12-22
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (3)

Publication Number Publication Date
FI783269A FI783269A (fi) 1979-04-29
FI63674B FI63674B (fi) 1983-04-29
FI63674C true FI63674C (fi) 1983-08-10

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
FI783269A FI63674C (fi) 1977-10-28 1978-10-26 Foerfarande foer isolering och rening av immunologiskt aktivt polyribosylribitolfosfat (prp)

Country Status (25)

Country Link
JP (1) JPS5480408A (zh)
AR (1) AR218932A1 (zh)
AU (1) AU520902B2 (zh)
BE (1) BE871586A (zh)
CA (1) CA1117866A (zh)
CH (1) CH649781A5 (zh)
DD (1) DD140701A5 (zh)
DE (1) DE2845745A1 (zh)
DK (1) DK154327C (zh)
ES (1) ES474611A1 (zh)
FI (1) FI63674C (zh)
FR (1) FR2407000B1 (zh)
GB (1) GB2007244B (zh)
GR (1) GR73991B (zh)
HU (1) HU178166B (zh)
IE (1) IE47474B1 (zh)
IL (1) IL55433A (zh)
IT (1) IT1107570B (zh)
NL (1) NL7810753A (zh)
NO (1) NO149611C (zh)
NZ (1) NZ188211A (zh)
PH (1) PH15882A (zh)
PL (1) PL210545A1 (zh)
SE (1) SE430753B (zh)
YU (1) YU250878A (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
ATE128628T1 (de) * 1990-08-13 1995-10-15 American Cyanamid Co Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
HU9400426D0 (en) * 1991-08-16 1994-05-30 Merck & Co Inc Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
IL24946A (en) * 1965-01-19 1969-05-28 Merck & Co Inc Process for preparing antibodies in cilus pertussis
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
NL174267B (nl) * 1969-05-20 Roussel Uclaf Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
FR2253499B1 (zh) * 1973-12-10 1977-11-04 Fabre Sa Pierre
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Also Published As

Publication number Publication date
NO149611C (no) 1984-05-23
CH649781A5 (de) 1985-06-14
IL55433A (en) 1982-09-30
YU250878A (en) 1983-12-31
ES474611A1 (es) 1980-01-16
NZ188211A (en) 1984-09-28
GB2007244A (en) 1979-05-16
GR73991B (zh) 1984-06-06
GB2007244B (en) 1982-03-31
DK154327C (da) 1989-04-03
PH15882A (en) 1983-04-13
DK154327B (da) 1988-11-07
JPS6231694B2 (zh) 1987-07-09
HU178166B (en) 1982-03-28
NL7810753A (nl) 1979-05-02
PL210545A1 (zh) 1980-02-25
DE2845745A1 (de) 1979-05-10
BE871586A (fr) 1979-04-27
AU4108178A (en) 1980-05-01
AU520902B2 (en) 1982-03-04
SE430753B (sv) 1983-12-12
NO783635L (no) 1979-05-02
DK479578A (da) 1979-04-29
DD140701A5 (de) 1980-03-26
IL55433A0 (en) 1978-10-31
IT1107570B (it) 1985-11-25
IE47474B1 (en) 1984-03-21
SE7811192L (sv) 1979-04-29
FI783269A (fi) 1979-04-29
NO149611B (no) 1984-02-13
IT7851621A0 (it) 1978-10-24
FI63674B (fi) 1983-04-29
AR218932A1 (es) 1980-07-15
FR2407000B1 (zh) 1983-01-21
IE782146L (en) 1979-04-28
FR2407000A1 (zh) 1979-05-25
DE2845745C2 (zh) 1987-10-01
JPS5480408A (en) 1979-06-27
CA1117866A (en) 1982-02-09

Similar Documents

Publication Publication Date Title
US4220717A (en) Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4197290A (en) Vaccine
Frommhagen et al. The role of aggregated γ-globulins in the anticomplementary activity of human and animal sera
US4196192A (en) Combined Haemophilus influenzae type b and pertussis vaccine
Ferretti et al. Cross-reactivity of Streptococcus mutans antigens and human heart tissue
US4816253A (en) Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
US4428931A (en) Bacterial toxoids and gram-negative immune globulin therefrom
US4567041A (en) Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
US4488991A (en) Bacterial toxoids and gram-negative immune globulin therefrom
FI63674C (fi) Foerfarande foer isolering och rening av immunologiskt aktivt polyribosylribitolfosfat (prp)
Kantor et al. Preparation and antigenicity of M protein released from group A, type 1 streptococcal cell walls by phage-associated lysin
US3636192A (en) Meningococcal polysaccharide vaccines
KR100266556B1 (ko) 백일해균의 방어성분의 분리방법
IE44943B1 (en) Tumor antigen and process for the preparation thereof
EP0080021B1 (en) Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
KR970002614B1 (ko) 백일해 내독소의 제거방법, 백일해 톡소이드 및 그 제조방법
Salaman The combining properties of vaccinia virus with the antibodies demonstrable in anti-vaccinal serum
US3674863A (en) Polyvalent immunizing agents and methods for their production
US4009257A (en) Preparation of immunosuppressive materials
Ushiba et al. Characterization of “Clearance” factor and “Cell-bound” antibody in experimental typhoid
US4001080A (en) Production of immunological materials
Allen et al. Labile inhibitor of lymphocyte transformation in plasma from a patient with subacute sclerosing panencephalitis
Hunter et al. Response of mice to rabbit Fab′ 2 and Fab′: Thymus independence of IgM response and thymus dependence of IgG response
US3208909A (en) Anaerobic process for production of a gel-adsorbed anthrax immunizing antigen
RU2456996C1 (ru) Способ получения очищенной в-субъединицы холерного токсина из рекомбинантного штамма vibrio cholerae

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: AMERICAN CYANAMID COMPANY